Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma
Escudier B, Chen I, Maneval E, Flodgren P, Peschel C, Fountzilas G, Mulder S, Srinivas S, Harmenberg U, Gillessen Sommer S, Roigas J, Vogelzang N. Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:4068-75.
Sep 1, 2009
Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma
Sep 1, 2009
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:4068-75
Escudier Bernard, Chen Isan, Maneval Edna Chow, Flodgren Per, Peschel Christian, Fountzilas George, Mulder Sasja F, Srinivas Sandhya, Harmenberg Ulrika, Gillessen Sommer Silke, Roigas Jan, Vogelzang Nicholas J
more
